SCHEMBL21123720

SCHEMBL21123720

Clc1cccc(-c2cccc3c2ccc2c(-c4ccccc4)cccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NUDT1 P36639 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
GAA P10253 1/20 0.45
CYP2A6 P11509 1/20 0.45
NR1I3 Q14994 1/20 0.43
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25681057 0.96 NPC1 (0.48) NPC1RAB9ATP53TSHRNFKB1
SCHEMBL25681050 0.92 NPC1 (0.48) NPC1RAB9ATP53TSHRNFKB1
SCHEMBL5050877 0.87 CYP2A6 (0.52) NPC1RAB9ATP53TSHRNFKB1
SCHEMBL8434860 0.84 SERPINE1 (0.50) RAB9ANUDT1ADORA2AADORA1CYP2A6
SCHEMBL21124583 0.83 CYP1A2 (0.58) TSHRSMN1; SMN2MEN1KMT2AGAA
SCHEMBL9862849 0.83 NPC1 (0.50) NPC1RAB9ATP53TSHRNFKB1
SCHEMBL28322994 0.82 METAP2 (0.48) MEN1KMT2ACYP2A6KDM4E
SCHEMBL30080985 0.82 METAP2 (0.48) MEN1KMT2ACYP2A6KDM4E
SCHEMBL25681090 0.82 SERPINE1 (0.49) RAB9ANUDT1ADORA2AADORA1CYP2A6
SCHEMBL23823574 0.82 GABRP (0.49) NPC1RAB9ATP53TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190207117-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190207117-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE MAOA, MAOB, COMT NPC1 2878/4885RAB9A 2251/4885TP53 4877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.